These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 32891809)

  • 1. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
    Desai K; Han B; Kuziez L; Yan Y; Zayed MA
    J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia.
    Furuyama T; Onohara T; Yamashita S; Yoshiga R; Yoshiya K; Inoue K; Morisaki K; Kyuragi R; Matsumoto T; Maehara Y
    Vascular; 2018 Dec; 26(6):626-633. PubMed ID: 30003829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional variation in outcomes for lower extremity vascular disease in the Vascular Quality Initiative.
    Soden PA; Zettervall SL; Shean KE; Vouyouka AG; Goodney PP; Mills JL; Hallett JW; Schermerhorn ML;
    J Vasc Surg; 2017 Sep; 66(3):810-818. PubMed ID: 28450103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions.
    Alameddine D; Damara FA; Pinto Rodriguez P; Huttler J; Slade MD; Arhuidese I; Aboian E; Ochoa Chaar CI
    Ann Vasc Surg; 2024 Jun; 103():47-57. PubMed ID: 38387798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
    Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
    J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia.
    Dosluoglu HH; Lall P; Blochle R; Harris LM; Dryjski ML
    J Vasc Surg; 2013 Jul; 58(1):98-104.e1. PubMed ID: 23683380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.
    Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S;
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroneal bypass versus endovascular peroneal intervention for critical limb ischemia.
    Mohapatra A; Boitet A; Malak O; Henry JC; Avgerinos ED; Makaroun MS; Hager ES; Chaer RA
    J Vasc Surg; 2019 Jan; 69(1):148-155. PubMed ID: 30580779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial.
    Conte MS; Azene E; Doros G; Gasper WJ; Hamza T; Kashyap VS; Guzman R; Mena-Hurtado C; Menard MT; Rosenfield K; Rowe VL; Strong M; Farber A
    J Vasc Surg; 2024 Jun; 79(6):1428-1437.e4. PubMed ID: 38368997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes with cilostazol after endovascular therapy of peripheral artery disease.
    Megaly M; Abraham B; Saad M; Mekaiel A; Soukas P; Banerjee S; Shishehbor MH
    Vasc Med; 2019 Aug; 24(4):313-323. PubMed ID: 31023156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Below-knee endovascular interventions have better outcomes compared to open bypass for patients with critical limb ischemia.
    Hicks CW; Najafian A; Farber A; Menard MT; Malas MB; Black JH; Abularrage CJ
    Vasc Med; 2017 Feb; 22(1):28-34. PubMed ID: 27928034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Is Associated with Improved Survival and Decreased Cardiac Events with No Impact on Patency and Limb Salvage after Revascularization for Peripheral Arterial Disease.
    Khan SZ; Rivero M; Nader ND; Cherr GS; Harris LM; Dryjski ML; Dosluoglu HH
    Ann Vasc Surg; 2019 Feb; 55():63-77. PubMed ID: 30081159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.
    Okazaki J; Matsuda D; Tanaka K; Ishida M; Kuma S; Morisaki K; Furuyama T; Maehara Y
    J Vasc Surg; 2018 Mar; 67(3):817-825. PubMed ID: 29032905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for peripheral vascular intervention and lower extremity bypass in kidney transplant recipients are superior to outcomes of patients remaining on dialysis.
    King RW; Malas MB; Brothers TE
    J Vasc Surg; 2019 Jun; 69(6):1849-1862.e6. PubMed ID: 30583898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.
    Stavroulakis K; Borowski M; Torsello G; Bisdas T;
    J Vasc Surg; 2017 Nov; 66(5):1534-1542. PubMed ID: 28807382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of isolated tibial disease on outcomes in the critical limb ischemic population.
    Gray BH; Grant AA; Kalbaugh CA; Blackhurst DW; Langan EM; Taylor SA; Cull DL
    Ann Vasc Surg; 2010 Apr; 24(3):349-59. PubMed ID: 20045628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, Antithrombotic Patterns, and Prognostic Outcomes in Claudication and Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy.
    Kawarada O; Zen K; Hozawa K; Obara H; Matsubara K; Yamamoto Y; Doijiri T; Tamai N; Ito S; Higashimori A; Kawasaki D; Doi H; Matsushita K; Tsukahara K; Noda K; Shimpo M; Tsuda Y; Sonoda S; Taniguchi T; Waseda K; Munehisa M; Taguchi E; Kinjo T; Sasaki Y; Yuba K; Yamaguchi S; Nakagami T; Ayabe S; Sakamoto S; Yagyu T; Ogata S; Nishimura K; Motomura H; Noguchi T; Ishihara M; Ogawa H; Yasuda S
    J Endovasc Ther; 2024 Aug; 31(4):622-633. PubMed ID: 36416475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia.
    Soga Y; Iida O; Hirano K; Suzuki K; Kawasaki D; Miyashita Y; Tsuchiya T; Nobuyoshi M
    J Vasc Surg; 2011 Dec; 54(6):1659-67. PubMed ID: 21872419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.